RemedLtd Past Earnings Performance

Past criteria checks 0/6

RemedLtd's earnings have been declining at an average annual rate of -20%, while the Medical Equipment industry saw earnings growing at 14.5% annually. Revenues have been growing at an average rate of 9.2% per year. RemedLtd's return on equity is 1%, and it has net margins of 4.3%.

Key information

-20.0%

Earnings growth rate

-24.2%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate9.2%
Return on equity1.0%
Net Margin4.3%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How RemedLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A302550 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2318,5367978,1042,940
30 Sep 2319,411-6027,6552,811
30 Jun 2321,510-886,8842,811
31 Mar 2321,6463,6626,5102,628
31 Dec 2221,3634,0006,4092,426
30 Sep 2222,8333,8196,5972,722
30 Jun 2221,2232,6086,5572,722
31 Mar 2221,4841,2556,3292,712
31 Dec 2120,1957526,0682,731
30 Sep 2116,848-2,6205,1012,358
30 Jun 2116,182-3,0054,7812,358
31 Mar 2113,451-4,4863,6822,885
31 Dec 2016,633-1,8344,2182,288
30 Sep 2020,7064,6524,8082,216
30 Jun 2021,7636,5343,7612,751
31 Mar 2022,4596,9074,1732,131
31 Dec 1918,5504,3633,8292,137

Quality Earnings: A302550 has a large one-off gain of ₩4.3B impacting its last 12 months of financial results to 31st December, 2023.

Growing Profit Margin: A302550's current net profit margins (4.3%) are lower than last year (18.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A302550's earnings have declined by 20% per year over the past 5 years.

Accelerating Growth: A302550's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: A302550 had negative earnings growth (-80.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (7.8%).


Return on Equity

High ROE: A302550's Return on Equity (1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.